Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

Monica Bertagnolli’s NIH confirmation hearing scheduled

October 13, 2023
Vol.49 No.38
Most NIH activities will cease immediately if government shuts down
Capitol Hill

Most NIH activities will cease immediately if government shuts down

September 29, 2023
Vol.49 No.36
By Matthew Bin Han Ong
NCI’s SEER marks 50 years of cancer surveillance
FreeTCL Archive

NCI’s SEER marks 50 years of cancer surveillance

September 29, 2023
Vol.49 No.36
NCI braces for funding cuts, shutdown
Capitol Hill

NCI braces for funding cuts, shutdown

September 22, 2023
Vol.49 No.35
By Matthew Bin Han Ong
In Brief

VCU Massey Cancer Center changes name to VCU Massey Comprehensive Cancer Center

September 22, 2023
Vol.49 No.35
Obstacles cleared for Bertagnolli’s confirmation as NIH director
Capitol Hill

Obstacles cleared for Bertagnolli’s confirmation as NIH director
Senate HELP Committee schedules hearing

September 15, 2023
Vol.49 No.34
By Matthew Bin Han Ong
In Brief

UK Markey attains Comprehensive designation

September 15, 2023
Vol.49 No.34
Moonshot and HHS agencies to develop standards for data interoperability
NCI

Moonshot and HHS agencies to develop standards for data interoperability

September 08, 2023
Vol.49 No.33
By Matthew Bin Han Ong
In Brief

Siteman Cancer Center receives Merit Extension from NCI

September 08, 2023
Vol.49 No.33
In Brief

Exact Sciences Lab and OncoExTra test selected by NCI for ComboMATCH clinical trials

September 08, 2023
Vol.49 No.33

Posts navigation

Previous1…212223…38Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
  • Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
  • CBER Director Vinay Prasad dared to “say no to drugs”
  • One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
  • As more people are surviving cancer, we must continue funding bold science

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account